Naveenganesh Muralidharan

Naveenganesh Muralidharan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
NMNaveenganesh Muralidharan
Naveenganesh Muralidharan
TJThatsinee Johnson
Thatsinee Johnson
LRLeyla Saeednia Rose
Leyla Saeednia Rose
MDMark Davis
Mark Davis
The Food and Drug Administration’s 2011 Process Validation Guidance and International Council for Harmonization Quality Guidelines recommend continued process verification (CPV) as a mandatory requirement for pharmaceutical, biopharmaceutical, and other regulated industries. As a part of product life cycle management, after process characterization in stage 1 and process qualification and validation in stage-2, CPV is performed as stage-3 validation during commercial manufacturing. CPV ensures that the process continues to remain within a validated state. CPV requires the collection and analysis of data related to critical quality attributes, critical material attributes, and critical process parameters on a minimum basis. Data is then used to elucidate process control regarding the capability to meet predefined specifications and stability via statistical process control tools. In statistical process control, control charts and Nelson rules are commonly used throughout the industry to monitor and trend data to ensure that a process remains in control. In the control chart, the mean value is taken as the center line, and 3σ limits are placed on either side of the center line. In CPV, manufactured lots are summarized, trended, and discussed at a cross-functional level at pre-defined intervals (either weekly, bi-weekly, or even monthly) based on the batch run rate. A cross-functional team assesses details regarding 1) violation frequency, 2) statistical strength of the signal, 3) violation magnitude and its impact on process or quality, and 4) any potential root causes for out-of-expectation or out-of-trend signals. The cross-functional team must analyze whether any signal identified by the control chart is reliable and must determine whether corrective action should be taken and justify the decision in the CPV meeting minutes based on statistical strength and reliability of the signal. However, basic control charts are susceptible to false alarms and nuisance alarms. Therefore, it is imperative to understand the assumptions behind control charts and the inherent false alarm rates for different Nelson rules. In this article, the authors have detailed the assumptions behind the usage of control charts, the rate of false alarms for different Nelson rules, the impact of skewness and kurtosis of a data distribution on the false alarm rate, and methods for optimizing control chart design by reducing false alarm rates and nuisance signals.

1 January 2024
Verified
Journal Article
Open access
PDF file
NMNaveenganesh Muralidharan
Naveenganesh Muralidharan
EBEmma Bolduc
Emma Bolduc
MDMark Davis
Mark Davis
Mammalian cells used in the production of biologics frequently switch from glucose to lactate as a source of energy, a process known as a lactate metabolic shift. While this response is desirable because it leads to high yields, it does not occur spontaneously nor is it well understood. Even in highly controlled commercial manufacturing facilities, some batches undergo a lactate metabolic shift while others do not. Here we review our current understanding of the bioreactor operating parameters that may have an impact on the lactate metabolic shift, including pH, pCO2, and glucose and lactate together with conditions used for media preparation, filtration, batching, and equilibration. The information presented might be used to troubleshoot problems leading to inconsistent lactate metabolic shifts and the development of more effective control strategies. Keywords Bioprocessing • Upstream cell culture • Mammalian cell • Lactate metabolic shift • Upstream control strategy

1 January 2024
Verified
Journal Article
Open access
PDF file
NMNaveenganesh Muralidharan
Naveenganesh Muralidharan
EBEmma Bolduc
Emma Bolduc
MDMark Davis
Mark Davis
Mammalian cells used in the production of biologics frequently switch from glucose to lactate as a source of energy, a process known as a lactate metabolic shift. While this response is desirable because it leads to high yields, it does not occur spontaneously nor is it well understood. Even in highly controlled commercial manufacturing facilities, some batches undergo a lactate metabolic shift while others do not. Here we review our current understanding of the bioreactor operating parameters that may have an impact on the lactate metabolic shift, including pH, pCO2, and glucose and lactate together with conditions used for media preparation, filtration, batching, and equilibration. The information presented might be used to troubleshoot problems leading to inconsistent lactate metabolic shifts and the development of more effective control strategies.